KGKarim Guessous

Karim Guessous

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karim Guessous has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • A. Mebazaa

    AP-HP, Hôpital Lariboisière, Paris, France

    1 shared publication
  • B. Glezerson

    The Montréal Neurological Institute and Hospital, McGill University, Montréal, Canada

    1 shared publication
  • C. Levé

    AP-HP, Hôpital Lariboisière, Paris, France

    1 shared publication
  • C. Paquet

    Cognitive Neurology Center, Memory department, Saint-Louis Lariboisière-Fernand Widal Hospital, APHP, Université Paris Cité INSERU1144, France

    1 shared publication
  • C. Touchard

    AP-HP, Hôpital Lariboisière, Paris, France

    1 shared publication
  • Cyril Touchard

    AP-HP, Hôpital Lariboisière, Departement d'Anesthésie-Réanimation, Paris, France, Université Paris Cité, Boulogne-Billancourt, France

    1 shared publication

Latest Publications

  • In Response

    by Cyril Touchard, Karim Guessous, Jérôme Cartailler

  • Intraoperative Electroencephalography Alpha-Band Power Is a Better Proxy for Preoperative Low MoCA Under Propofol Compared With Sevoflurane

    by K. Guessous, C. Touchard, B. Glezerson, C. Levé, D. Sabbagh, A. Mebazaa, E. Gayat, C. Paquet, F. Vallée, J. Cartailler

    BACKGROUND: Preoperative abnormal cognitive status is a risk factor for postoperative complications yet remains underdiagnosed. During propofol general anesthesia, intraoperative electroencephalography (EEG) variables, such as alpha band power (α-BP), correlate with cognitive status. This relationship under sevoflurane is unclear. We investigated whether EEG biomarkers of poor cognitive status found under propofol could be extended to sevoflurane. METHODS: In this monocentric prospective observational study, 106 patients with intraoperative EEG monitoring were included (propofol/sevoflurane = 55/51). We administered the Montreal Cognitive Assessment (MoCA) scale to identify abnormal cognition (low MoCA) 1 day before intervention. EEG variables included delta to beta frequency band powers. Results were adjusted to age and drug dosage. We assessed depth of anesthesia (DoA) using the spectral edge frequency (SEF95) and maintained it within (8–13) Hz. RESULTS: The difference in α-BP between low and normal MoCA patients was significantly larger among propofol patients (propofol: 4.3 ± 4.8 dB versus sevoflurane: 1.5 ± 3.4 dB, P = .022). SEF95 and age were not statistically different between sevoflurane and propofol groups. After adjusting to age and dose, low α-BP was significantly associated with low MoCA under propofol (odds ratio [OR] [confidence interval {CI}] = 0.39 [0.16–0.94], P = .034), but not under sevoflurane, where theta-band power was significantly associated with low MoCA (OR [CI] = 0.31 [0.13–0.73], P = .007). CONCLUSIONS: We suggest that intraoperative EEG biomarkers of abnormal cognition differ between propofol and sevoflurane under general anesthesia.